Skip to main content
Premium Trial:

Request an Annual Quote

Large Scale Biology Looks to Auction Proteomics-Related Items

NEW YORK, June 9 (GenomeWeb News) - Large Scale Biology will auction off proteomic equipment on June 16, GenomeWeb News has learned.

 

DoveBid, a capital asset auction and valuation company, announced today that it will webcast the auction of LSBC assets described on sales flyers as "surplus to [the company's] continuing operations." The auction will be held in Germantown, Md., with previews available at that site on June 15, and at Vacaville, Calif., by appointment only, prior to that.

 

Items for auction include a Micromass Q-TOF Mass Spec; and HPLC Systems manufactured by Perseptive Bio Systems, Micro Tech, and Agilent; as well as liquid handlers, centrifuges, and robotic plate systems.

 

The company in November announced that it was shutting down its fee-for-service proteomics contract business as part of a repositioning of the firm as a product company.

 

The auction will be held on June 16 from 9 am until 2 pm Pacific Daylight Time. Details about the event can be found here.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.